Construction of differential expression plasmids of NGF to detect its influence on PC12 cell neuronal differentiation
- Authors:
- Yu Liu
- Lili Zou
- Peng Wang
- Jingxuan Zhou
- Chunling Yuan
- Jun Wang
-
Affiliations: Central Laboratory, The People's Hospital of China Three Gorges University, Yichang, Hubei 443000, P.R. China - Published online on: February 14, 2021 https://doi.org/10.3892/etm.2021.9794
- Article Number: 363
-
Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Hutchings C, Phillips JA and Djamgoz MBA: Nerve input to tumours: Pathophysiological consequences of a dynamic relationship. Biochim Biophys Acta Rev Cancer. 1874(188411)2020.PubMed/NCBI View Article : Google Scholar | |
|
Cervantes-Villagrana RD, Albores-Garcia D, Cervantes-Villagrana AR and García-Acevez SJ: Tumor-induced neurogenesis and immune evasion as targets of innovative anti-cancer therapies. Signal Transduct Target Ther. 5(99)2020.PubMed/NCBI View Article : Google Scholar | |
|
Jiang SH, Hu LP, Wang X, Li J and Zhang ZG: Neurotransmitters: Emerging targets in cancer. Oncogene. 39:503–515. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Zhu Y, Zhang GN, Shi Y, Cui L, Leng XF and Huang JM: Perineural invasion in cervical cancer: Pay attention to the indications of nerve-sparing radical hysterectomy. Ann Transl Med. 7(203)2019.PubMed/NCBI View Article : Google Scholar | |
|
Magnon C, Hall SJ, Lin J, Xue X, Gerber L, Freedland SJ and Frenette PS: Autonomic nerve development contributes to prostate cancer progression. Science. 341(1236361)2013.PubMed/NCBI View Article : Google Scholar | |
|
Deborde S, Omelchenko T, Lyubchik A, Zhou Y, He S, McNamara WF, Chernichenko N, Lee SY, Barajas F, Chen CH, et al: Schwann cells induce cancer cell dispersion and invasion. J Clin Invest. 126:1538–1554. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Ayala GE, Dai H, Powell M, Li R, Ding Y, Wheeler TM, Shine D, Kadmon D, Thompson T, Miles BJ, et al: Cancer-related axonogenesis and neurogenesis in prostate cancer. Clin Cancer Res. 14:7593–7603. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Dai H, Li R, Wheeler T, Ozen M, Ittmann M, Anderson M, Wang Y, Rowley D, Younes M and Ayala GE: Enhanced survival in perineural invasion of pancreatic cancer: An in vitro approach. Hum Pathol. 38:299–307. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Albo D, Akay CL, Marshall CL, Wilks JA, Verstovsek G, Liu H, Agarwal N, Berger DH and Ayala GE: Neurogenesis in colorectal cancer is a marker of aggressive tumor behavior and poor outcomes. Cancer. 117:4834–4845. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Huang D, Su S, Cui X, Shen X, Zeng Y, Wu W, Chen J, Chen F, He C, Liu J, et al: Nerve fibers in breast cancer tissues indicate aggressive tumor progression. Medicine (Baltimore). 93(e172)2014.PubMed/NCBI View Article : Google Scholar | |
|
Zhao Q, Yang Y, Liang X, Du G, Liu L, Lu L, Dong J, Han H and Zhang G: The clinicopathological significance of neurogenesis in breast cancer. BMC Cancer. 14(484)2014.PubMed/NCBI View Article : Google Scholar | |
|
Chowdary PD, Che DL and Cui B: Neurotrophin signaling via long-distance axonal transport. Annu Rev Phys Chem. 63:571–594. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Vanderhaeghen P and Cheng HJ: Guidance molecules in axon pruning and cell death. Cold Spring Harb Perspect Biol. 2(a001859)2010.PubMed/NCBI View Article : Google Scholar | |
|
Mancino M, Ametller E, Gascon P and Almendro V: The neuronal influence on tumor progression. Biochim Biophys Acta. 1816:105–118. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Adriaenssens E, Vanhecke E, Saule P, Mougel A, Page A, Romon R, Nurcombe V, Le Bourhis X and Hondermarck H: Nerve growth factor is a potential therapeutic target in breast cancer. Cancer Res. 68:346–351. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Mandelker DL, Yamashita K, Tokumaru Y, Mimori K, Howard DL, Tanaka Y, Carvalho AL, Jiang WW, Park HL, Kim MS, et al: PGP9.5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma. Cancer Res. 65:4963–4968. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Lee YM, Lee JY, Kim MJ, Bae HI, Park JY, Kim SG and Kim DS: Hypomethylation of the protein gene product 9.5 promoter region in gallbladder cancer and its relationship with clinicopathological features. Cancer Sci. 97:1205–1210. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Wen W, Liu G, Jin K and Hu X: TGF-β1 induces PGP9.5 expression in CAFs to promote the growth of colorectal cancer cells. Oncol Rep. 37:115–122. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Ohta T and Fukuda M: Ubiquitin and breast cancer. Oncogene. 23:2079–2088. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Dollé L, Adriaenssens E, El Yazidi-Belkoura I, Le Bourhis X, Nurcombe V and Hondermarck H: Nerve growth factor receptors and signaling in breast cancer. Curr Cancer Drug Targets. 4:463–470. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Bradshaw RA, Pundavela J, Biarc J, Chalkley RJ, Burlingame AL and Hondermarck H: NGF and ProNGF: Regulation of neuronal and neoplastic responses through receptor signaling. Adv Biol Regul. 58:16–27. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Liss MA, Gordon A, Morales B, Osann K, Skarecky D, Lusch A, Zaldivar F and Ahlering TE: Urinary nerve growth factor as an oncologic biomarker for prostate cancer aggressiveness. Urol Oncol. 32:714–719. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Mei F, Liu JY and Xue WC: Histological grading of invasive breast carcinoma: Nottingham histological grading system. Zhonghua Bing Li Xue Za Zhi. 48:659–664. 2019.PubMed/NCBI View Article : Google Scholar : (In Chinese). | |
|
Rao SJ, Rao JBM and Rao PJ: Immunohistochemical analysis of stromal fibrocytes and myofibroblasts to envision the invasion and lymph node metastasis in oral squamous cell carcinoma. J Oral Maxillofac Pathol. 21:218–223. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Dikmen M: Comparison of the effects of curcumin and RG108 on NGF-induced PC-12 Adh cell differentiation and neurite outgrowth. J Med Food. 20:376–384. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Schimmelpfeng J, Weibezahn KF and Dertinger H: Quantification of NGF-dependent neuronal differentiation of PC-12 cells by means of neurofilament-L mRNA expression and neuronal outgrowth. J Neurosci Methods. 139:299–306. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Chan GKL, Hu WWH, Zheng ZX, Huang M, Lin YXY, Wang CY, Gong AGW, Yang XY, Tsim KWK and Dong TTX: Quercetin potentiates the NGF-induced effects in cultured PC 12 cells: Identification by HerboChips showing a binding with NGF. Evid Based Complement Alternat Med. 1502457:2018.PubMed/NCBI View Article : Google Scholar | |
|
Cai S, Cheng X, Liu Y, Lin Z, Zeng W, Yang C, Liu L, Chukwuebuka OA and Li W: EYA1 promotes tumor angiogenesis by activating the PI3K pathway in colorectal cancer. Exp Cell Res. 367:37–46. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Ernst BP, Mikstas C, Stover T, Stauber R and Strieth S: Association of eIF4E and SPARC expression with lymphangiogenesis and lymph node metastasis in hypopharyngeal cancer. Anticancer Res. 38:699–706. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Wang J, Huang Y, Zhang J, Xing B, Xuan W, Wang H, Huang H, Yang J and Tang J: NRP-2 in tumor lymphangiogenesis and lymphatic metastasis. Cancer Lett. 418:176–184. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Zanotto-Filho A, Rajamanickam S, Loranc E, Masamsetti VP, Gorthi A, Romero JC, Tonapi S, Gonçalves RM, Reddick RL, Benavides R, et al: Sorafenib improves alkylating therapy by blocking induced inflammation, invasion and angiogenesis in breast cancer cells. Cancer Lett. 425:101–115. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Xia Y, Wei Y, Li ZY, Cai XY, Zhang LL, Dong XR, Zhang S, Zhang RG, Meng R, Zhu F and Wu G: Catecholamines contribute to the neovascularization of lung cancer via tumor-associated macrophages. Brain Behav Immun. 81:111–121. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Kim-Fuchs C, Le CP, Pimentel MA, Shackleford D, Ferrari D, Angst E, Hollande F and Sloan EK: Chronic stress accelerates pancreatic cancer growth and invasion: A critical role for beta-adrenergic signaling in the pancreatic microenvironment. Brain Behav Immun. 40:40–47. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Lamkin DM, Sloan EK, Patel AJ, Chiang BS, Pimentel MA, Ma JC, Arevalo JM, Morizono K and Cole SW: Chronic stress enhances progression of acute lymphoblastic leukemia via β-adrenergic signaling. Brain Behav Immun. 26:635–641. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Liu Y, Yu X and Zhuang J: Epinephrine stimulates cell proliferation and induces chemoresistance in myeloma cells through the β-adrenoreceptor in vitro. Acta Haematol. 138:103–110. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Wu FQ, Fang T, Yu LX, Lv GS, Lv HW, Liang D, Li T, Wang CZ, Tan YX, Ding J, et al: ADRB2 signaling promotes HCC progression and sorafenib resistance by inhibiting autophagic degradation of HIF1alpha. J Hepatol. 65:314–324. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Lu R, Fan C, Shangguan W, Liu Y, Li Y, Shang Y, Yin D, Zhang S, Huang Q, Li X, et al: Neurons generated from carcinoma stem cells support cancer progression. Signal Transduct Target Ther. 2(16036)2017.PubMed/NCBI View Article : Google Scholar | |
|
Marusyk A and Polyak K: Tumor heterogeneity: Causes and consequences. Biochim Biophys Acta. 1805:105–117. 2010.PubMed/NCBI View Article : Google Scholar | |
|
West NR, McCuaig S, Franchini F and Powrie F: Emerging cytokine networks in colorectal cancer. Nat Rev Immunol. 15:615–629. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Mantovani A, Barajon I and Garlanda C: IL-1 and IL-1 regulatory pathways in cancer progression and therapy. Immunol Rev. 281:57–61. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Berraondo P, Sanmamed MF, Ochoa MC, Etxeberria I, Aznar MA, Pérez-Gracia JL, Rodríguez-Ruiz ME, Ponz-Sarvise M, Castañón E and Melero I: Cytokines in clinical cancer immunotherapy. Br J Cancer. 120:6–15. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Galdiero MR, Marone G and Mantovani A: Cancer inflammation and cytokines. Cold Spring Harb Perspect Biol. 10(a028662)2018.PubMed/NCBI View Article : Google Scholar | |
|
Najafi M, Goradel NH, Farhood B, Salehi E, Solhjoo S, Toolee H, Kharazinejad E and Mortezaee K: Tumor microenvironment: Interactions and therapy. J Cell Physiol. 234:5700–5721. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Yao M, Brummer G, Acevedo D and Cheng N: Cytokine regulation of metastasis and tumorigenicity. Adv Cancer Res. 132:265–367. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Hong JT, Son DJ, Lee CK, Yoon DY, Lee DH and Park MH: Interleukin 32, inflammation and cancer. Pharmacol Ther. 174:127–137. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Setrerrahmane S and Xu H: Tumor-related interleukins: Old validated targets for new anti-cancer drug development. Mol Cancer. 16(153)2017.PubMed/NCBI View Article : Google Scholar | |
|
Folkman J, Merler E, Abernathy C and Williams G: Isolation of a tumor factor responsible for angiogenesis. J Exp Med. 133:275–288. 1971.PubMed/NCBI View Article : Google Scholar | |
|
Fischer C, Jonckx B, Mazzone M, Zacchigna S, Loges S, Pattarini L, Chorianopoulos E, Liesenborghs L, Koch M, De Mol M, et al: Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels. Cell. 131:463–475. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Fischer C, Mazzone M, Jonckx B and Carmeliet P: FLT1 and its ligands VEGFB and PlGF: Drug targets for anti-angiogenic therapy? Nat Rev Cancer. 8:942–956. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Ellis LM and Hicklin DJ: VEGF-targeted therapy: Mechanisms of anti-tumour activity. Nat Rev Cancer. 8:579–591. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Alitalo K, Tammela T and Petrova TV: Lymphangiogenesis in development and human disease. Nature. 438:946–953. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Stacker SA, Baldwin ME and Achen MG: The role of tumor lymphangiogenesis in metastatic spread. FASEB J. 16:922–934. 2002.PubMed/NCBI View Article : Google Scholar | |
|
Lala PK, Nandi P and Majumder M: Roles of prostaglandins in tumor-associated lymphangiogenesis with special reference to breast cancer. Cancer Metastasis Rev. 37:369–384. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Dieterich LC and Detmar M: Tumor lymphangiogenesis and new drug development. Adv Drug Deliv Rev. 99:148–160. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Garnier L, Gkountidi AO and Hugues S: Tumor-associated lymphatic vessel features and immunomodulatory functions. Front Immunol. 10(720)2019.PubMed/NCBI View Article : Google Scholar | |
|
Paduch R: The role of lymphangiogenesis and angiogenesis in tumor metastasis. Cell Oncol (Dordr). 39:397–410. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Achen MG and Stacker SA: Tumor lymphangiogenesis and metastatic spread-new players begin to emerge. Int J Cancer. 119:1755–1760. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Seifert P, Benedic M and Effert P: Nerve fibers in tumors of the human urinary bladder. Virchows Arch. 440:291–297. 2002.PubMed/NCBI View Article : Google Scholar | |
|
Seifert P and Spitznas M: Axons in human choroidal melanoma suggest the participation of nerves in the control of these tumors. Am J Ophthalmol. 133:711–713. 2002.PubMed/NCBI View Article : Google Scholar | |
|
Ventura S, Pennefather J and Mitchelson F: Cholinergic innervation and function in the prostate gland. Pharmacol Ther. 94:93–112. 2002.PubMed/NCBI View Article : Google Scholar | |
|
Mitchell BS, Schumacher U, Stauber VV and Kaiserling E: Are breast tumours innervated? Immunohistological investigations using antibodies against the neuronal marker protein gene product 9.5 (PGP 9.5) in benign and malignant breast lesions. Eur J Cancer. 30A:1100–1103. 1994.PubMed/NCBI View Article : Google Scholar | |
|
Kayahara M, Nakagawara H, Kitagawa H and Ohta T: The nature of neural invasion by pancreatic cancer. Pancreas. 35:218–223. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Ayala GE, Wheeler TM, Shine HD, Schmelz M, Frolov A, Chakraborty S and Rowley D: In vitro dorsal root ganglia and human prostate cell line interaction: Redefining perineural invasion in prostate cancer. Prostate. 49:213–223. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Godbout JP and Glaser R: Stress-induced immune dysregulation: Implications for wound healing, infectious disease and cancer. J Neuroimmune Pharmacol. 1:421–427. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Lee JW, Shahzad MM, Lin YG, Armaiz-Pena G, Mangala LS, Han HD, Kim HS, Nam EJ, Jennings NB, Halder J, et al: Surgical stress promotes tumor growth in ovarian carcinoma. Clin Cancer Res. 15:2695–2702. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Thaker PH, Han LY, Kamat AA, Arevalo JM, Takahashi R, Lu C, Jennings NB, Armaiz-Pena G, Bankson JA, Ravoori M, et al: Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med. 12:939–944. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Entschladen F, Drell TL IV, Lang K, Joseph J and Zaenker KS: Tumour-cell migration, invasion, and metastasis: Navigation by neurotransmitters. Lancet Oncol. 5:254–258. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Geldof AA, Van Haarst EP and Newling DW: Neurotrophic factors in prostate and prostatic cancer. Prostate Cancer Prostatic Dis. 1:236–241. 1998.PubMed/NCBI View Article : Google Scholar | |
|
Ricci A, Greco S, Mariotta S, Felici L, Bronzetti E, Cavazzana A, Cardillo G, Amenta F, Bisetti A and Barbolini G: Neurotrophins and neurotrophin receptors in human lung cancer. Am J Respir Cell Mol Biol. 25:439–446. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Dollé L, El Yazidi-Belkoura I, Adriaenssens E, Nurcombe V and Hondermarck H: Nerve growth factor overexpression and autocrine loop in breast cancer cells. Oncogene. 22:5592–5601. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Chédotal A, Kerjan G and Moreau-Fauvarque C: The brain within the tumor: New roles for axon guidance molecules in cancers. Cell Death Differ. 12:1044–1056. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Sofroniew MV, Howe CL and Mobley WC: Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci. 24:1217–1281. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Melincovici CS, Boşca AB, Şuşman S, Mărginean M, Mihu C, Istrate M, Moldovan IM, Roman AL and Mihu CM: Vascular endothelial growth factor (VEGF)-key factor in normal and pathological angiogenesis. Rom J Morphol Embryol. 59:455–467. 2018.PubMed/NCBI | |
|
Deyama S, Bang E, Kato T, Li XY and Duman RS: Neurotrophic and antidepressant actions of brain-derived neurotrophic factor require vascular endothelial growth factor. Biol Psychiatry. 86:143–152. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Kutcher ME, Klagsbrun M and Mamluk R: VEGF is required for the maintenance of dorsal root ganglia blood vessels but not neurons during development. FASEB J. 18:1952–1954. 2004.PubMed/NCBI View Article : Google Scholar |
